Original release date: May 16, 2023
Access to this course expires on:  April 11, 2026 at 11:59 PM Pacific Time
CME 12

Course Description
Pathology of the lower anogenital tract, lower urinary tract, prostate, uterus, and cervix has advanced with the identification of relevant genes, better immunohistochemical markers, and the ability to readily detect human papillomavirus (HPV) using RNA in situ hybridization. New entities have recently been recognized, refinements to existing ones are possible, and new treatment, particularly immunotherapy, are available. Expert faculty will discuss newer entities and pitfalls in these areas, while also addressing diagnostic challenges in cytology and newly adopted classification schemes.

Target Audience

Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives

Upon completion of this educational activity, learners will be able to:

• Discuss novel recently described human papilloma virus (HPV)-associated and HPV-independent neoplasms of the lower genital tract
• Present a modern viewpoint for grading prostatic carcinoma
• Address pitfalls in diagnosing urothelial neoplasms versus those from adjoining sites, including treatment related pitfalls
• Consider mimickers of common neoplasms of the anogenital and urothelial tracts
• Establish systematic approach to diagnostic challenges in cytology

Continuing Medical Education

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 12 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any financial relationship(s) that have occurred within the last 24 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and mitigated all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Elizabeth Montgomery, MD, Andre Pinto, MD, Christopher J. VandenBussche, MD, PhD, and Sara Wobker, MD, MPH

The following IM coordinator reported no relevant financial relationships: Andrew Folpe, MD

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME credit, all learners must complete the evaluation. Learners can now self-submit CME on all earned certificates. View and print your certificates by clicking here.

USCAP members receive a discount on all e-Learning courses. Not A Member? Click Here to sign up today.